With Q1 earnings season well underway, it was Johnson & Johnson (JNJ) giving investors a peek at how the broader healthcare sector might perform. The healthcare giant beat expectations on Tuesday in revenue ($24.1 billion actual versus $23.6 expected) and earnings per share ($2.70 actual versus $2.66 expected). JNJ’s earnings could set a precedence on […]

The post What Johnson & Johnson Earnings Signal for Healthcare ETFs appeared first on ETF Trends.